Status:
UNKNOWN
Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day
Lead Sponsor:
Tu Du Hospital
Conditions:
Assisted Reproductive Technology
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
The main objective of this study is to compare clinical pregnancy rates between two groups of women who have progesterone levels below 10 ng/mL on the day of frozen embryo transfer: group 1 (vaginal m...
Detailed Description
Trial Design: Single center, longitudinal, randomized, interventional, controlled, pharmacological study, enrolling women attending clinical Centers of medically assisted reproduction (ART). The stu...
Eligibility Criteria
Inclusion
- Patients undergone ART with frozen embryo transfer, blastocyst or cleavaged stage embryo transfer, from 18-45 years of age
- Normal BMI
- HRT for Endometrial preparation in FET cycles
Exclusion
- Oocyte donor cycles
- Surrogacy
- IVM
- PGT
- Abnormal Uterine (firbroids 0 -\> 3 according to FIGO classification, polyp, adenomyosis, congenital malformation)
- Uterus fibroids type 4,5 (Figo classification) \> 4cm
- History of recurrent implantation failure
- Endometrial thickness \<7mm on the day of ET
- Cesarean scar defect (isthmocele)
Key Trial Info
Start Date :
May 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 20 2024
Estimated Enrollment :
824 Patients enrolled
Trial Details
Trial ID
NCT04897269
Start Date
May 20 2021
End Date
June 20 2024
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Infertility of Tu Du hospital
Ho Chi Minh City, Vietnam, 70000